Harbour Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$616K Buy
7,103
+5,304
+295% +$464K 0.01% 959
2025
Q4
$153K Buy
1,799
+1,300
+261% +$104K ﹤0.01% 1420
2025
Q3
$36.2K Hold
499
﹤0.01% 2042
2025
Q2
$32.7K Buy
499
+61
+14% +$3.97K ﹤0.01% 2008
2025
Q1
$30.9K Buy
438
+138
+46% +$9.59K ﹤0.01% 1990
2024
Q4
$19.7K Hold
300
﹤0.01% 2133
2024
Q3
$21.2K Hold
300
﹤0.01% 2028
2024
Q2
$19.9K Sell
300
-18
-6% -$1.18K ﹤0.01% 1957
2024
Q1
$21.6K Hold
318
﹤0.01% 1919
2023
Q4
$19.7K Hold
318
﹤0.01% 1885
2023
Q3
$18.8K Hold
318
﹤0.01% 1768
2023
Q2
$19K Hold
318
﹤0.01% 1777
2023
Q1
$18.6K Buy
318
+18
+6% +$1.08K ﹤0.01% 1773
2022
Q4
$18.6K Hold
300
﹤0.01% 1711
2022
Q3
$19K Hold
300
﹤0.01% 1673
2022
Q2
$19K Buy
+300
New +$19K ﹤0.01% 1673
2021
Q4
$21K Sell
309
-54
-15% -$3.42K ﹤0.01% 1650
2021
Q3
$22K Hold
363
﹤0.01% 2247
2021
Q2
$22K Buy
363
+300
+476% +$18.2K ﹤0.01% 2293
2021
Q1
$4K Buy
+63
New +$3.8K ﹤0.01% 2982

Other funds holding IHE